PRGO - Perrigo Company plc

NYSE - NYSE Delayed Price. Currency in USD
86.50
+2.46 (+2.93%)
At close: 4:02PM EST
Stock chart is not supported by your current browser
Previous Close84.04
Open85.12
Bid0.00 x 0
Ask0.00 x 0
Day's Range84.12 - 86.58
52 Week Range63.68 - 91.73
Volume2,098,862
Avg. Volume1,226,461
Market Cap12.183B
Beta0.71
PE Ratio (TTM)N/A
EPS (TTM)-9.21
Earnings DateFeb 26, 2018 - Mar 2, 2018
Forward Dividend & Yield0.64 (0.76%)
Ex-Dividend Date2017-11-30
1y Target Est88.44
Trade prices are not sourced from all markets
  • Reuters2 days ago

    Perrigo lines up bid for Merck's consumer health unit - sources

    LONDON/FRANKFURT (Reuters) - Generic drugmaker Perrigo (PRGO.N) has decided to enter the fray for Merck KGaA's (MRCG.DE) consumer health unit, sources told Reuters, and is preparing an indicative offer for the $4.7 billion business ahead of a deadline on Friday. Perrigo is expected to face competition from Swiss food giant Nestle (NESN.S) and the private equity owners of German drug firm Stada (STAGn.DE), which are also lining up non-binding offers for the maker of Seven Seas vitamins and Bion nutritional supplements, the sources said on Thursday. Merck's financial adviser JPMorgan wants to shortlist bidders for the business before the end of the year, they said.

  • Reuters2 days ago

    Perrigo lines up bid for Merck's consumer health unit -sources

    LONDON/FRANKFURT, Dec 14 (Reuters) - Generic drugmaker Perrigo has decided to enter the fray for Merck KGaA's consumer health unit, sources told Reuters, and is preparing an indicative offer for the $4.7 billion business ahead of a deadline on Friday. Perrigo is expected to face competition from Swiss food giant Nestle and the private equity owners of German drug firm Stada, which are also lining up non-binding offers for the maker of Seven Seas vitamins and Bion nutritional supplements, the sources said on Thursday. Merck's financial adviser JPMorgan wants to shortlist bidders for the business before the end of the year, they said.

  • Reuters2 days ago

    Perrigo preparing non-binding bid for Merck KgaA's consumer health unit -sources

    LONDON/FRANKFURT, Dec 14 (Reuters) - U.S. drugmaker Perrigo has decided to enter the fray for Merck KgaA's consumer health unit, sources told Reuters on Thursday, and is preparing an indicative offer for the $4.7 billion business ahead of the Dec. 15 deadline. Perrigo is expected to face competition from Swiss food giant Nestle and the private equity owners of German drug firm Stada, which are also lining up non-binding offers for the unit, the sources said. Merck's financial adviser JPMorgan wants to shortlist bidders for the business, which makes Seven Seas vitamins and Bion nutritional supplements, before the end of the year, they said.

  • Capital Cube8 days ago

    ETFs with exposure to Perrigo Co. Plc : December 8, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Perrigo Co. Plc Here are 5 ETFs with the largest exposure to PRGO-US. Comparing the performance and risk of Perrigo Co. Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Benzinga8 days ago

    Analyst: Despite Industry Woes, Investigations, And Management Shake-Up, Perrigo Is A Buy

    Perrigo Company plc Ordinary Shares (NYSE: PRGO )'s business has faced multiple pressures, including industry-wide price erosion, a legal battle for possible collusion in generic drug pricing along with ...

  • See what the IHS Markit Score report has to say about Perrigo Company PLC.
    Markit8 days ago

    See what the IHS Markit Score report has to say about Perrigo Company PLC.

    The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last month, growth of ETFs holding PRGO is favorable, with net inflows of $12.23 billion.

  • 5 Best GARP Stocks Based on PEG Ratio
    Zacks10 days ago

    5 Best GARP Stocks Based on PEG Ratio

    The price/earnings growth (PEG) ratio is a perfect example of a GARP strategy. A lower PEG ratio, preferably less than 1, is always better for GARP investors.

  • Perrigo Co. Plc breached its 50 day moving average in a Bearish Manner : PRGO-US : December 6, 2017
    Capital Cube10 days ago

    Perrigo Co. Plc breached its 50 day moving average in a Bearish Manner : PRGO-US : December 6, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Perrigo Co. Plc. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish ... Read more (Read more...)

  • See what the IHS Markit Score report has to say about Perrigo Company PLC.
    Markit12 days ago

    See what the IHS Markit Score report has to say about Perrigo Company PLC.

    The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.

  • Capital Cube19 days ago

    ETFs with exposure to Perrigo Co. Plc : November 27, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Perrigo Co. Plc Here are 5 ETFs with the largest exposure to PRGO-US. Comparing the performance and risk of Perrigo Co. Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Perrigo Announces the Launch of an AB Rated Generic Version of Mycolog® II Cream
    PR Newswire19 days ago

    Perrigo Announces the Launch of an AB Rated Generic Version of Mycolog® II Cream

    TASE: PRGO) today announced the launch of an AB rated generic version of Mycolog® II Cream (nystatin and triamcinolone acetonide cream USP, 100,000 units/gram and 1 mg/gram). Perrigo Executive Vice President and President Rx Pharmaceuticals John Wesolowski stated, "This launch exemplifies Perrigo's ongoing commitment to developing quality, high value alternatives in important treatment categories. Perrigo Company plc, a leading global healthcare company, delivers value to its customers and consumers by providing Quality Affordable Healthcare Products®.

  • Perrigo Announces the Launch of an AB Rated Generic Version of Exalgo® 32mg Extended Release Tablets
    PR Newswire19 days ago

    Perrigo Announces the Launch of an AB Rated Generic Version of Exalgo® 32mg Extended Release Tablets

    TASE: PRGO) today announced the launch of an AB rated generic version of Exalgo® 32mg extended release tablets (hydromorphone HCl) C-II. Exalgo® 32mg extended release tablets (hydromorphone HCl) C-II is an opioid agonist indicated for the management of moderate to severe pain in opioid tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time. Perrigo Executive Vice President and President Rx Pharmaceuticals John Wesolowski stated, "This launch is another example of the team's hard work in advancing our new product pipeline.

  • Perrigo Company Completes Divestiture Of API Business For $110 Million
    PR Newswire25 days ago

    Perrigo Company Completes Divestiture Of API Business For $110 Million

    Perrigo's CEO John T. Hendrickson stated, "Today's announcement furthers the strategic review process announced when I became CEO. Perrigo Company plc, a leading global healthcare company, delivers value to its customers and consumers by providing Quality Affordable Healthcare Products®. Founded in 1887 as a packager of home remedies, Perrigo has built a unique business model that is best described as the convergence of a fast-moving consumer goods company, a high-quality pharmaceutical manufacturing organization and a world-class supply chain network.

  • Zacks.com featured highlights: Boot Barn, Perrigo, Boise Cascade, DXC Technology and Koppers
    Zacks25 days ago

    Zacks.com featured highlights: Boot Barn, Perrigo, Boise Cascade, DXC Technology and Koppers

    Zacks.com featured highlights: Boot Barn, Perrigo, Boise Cascade, DXC Technology and Koppers

  • Perrigo Co. Plc breached its 50 day moving average in a Bearish Manner : PRGO-US : November 21, 2017
    Capital Cube25 days ago

    Perrigo Co. Plc breached its 50 day moving average in a Bearish Manner : PRGO-US : November 21, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Perrigo Co. Plc. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish ... Read more (Read more...)

  • Bet on These 5 GARP Stocks Based on Low PEG Ratio
    Zacks26 days ago

    Bet on These 5 GARP Stocks Based on Low PEG Ratio

    A lower PEG ratio, preferably less than 1, is always better for GARP investors.

  • See what the IHS Markit Score report has to say about Perrigo Company PLC.
    Markitlast month

    See what the IHS Markit Score report has to say about Perrigo Company PLC.

    Additionally, this was an improvement in sentiment as investors who seek to profit from falling equity prices reduced their short positions on October 25. Index (PMI) data, output in the Healthcare sector is rising.

  • Capital Cubelast month

    ETFs with exposure to Perrigo Co. Plc : November 13, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Perrigo Co. Plc Here are 5 ETFs with the largest exposure to PRGO-US. Comparing the performance and risk of Perrigo Co. Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Thomson Reuters StreetEventslast month

    Edited Transcript of PRGO earnings conference call or presentation 9-Nov-17 1:00pm GMT

    Q3 2017 Perrigo Company PLC Earnings Call

  • Benzingalast month

    RBC: Perrigo's Near-Term Risk Lessens, But Long-Term Issues Persist

    Perrigo Company plc Ordinary Shares (NYSE: PRGO ) impressed investors with third-quarter earnings Thursday and issued encouraging guidance that led some of Wall Street's bears to revisit their thesis on ...

  • Perrigo Company to Present at the Stifel 2017 Healthcare Conference
    PR Newswirelast month

    Perrigo Company to Present at the Stifel 2017 Healthcare Conference

    TASE) today announced that John T. Hendrickson, Perrigo Chief Executive Officer, will present at the 2017 Stifel Healthcare Conference at 8:45 AM EST on Tuesday, November 14, 2017.  Interested parties can access the presentation webcast at http://perrigo.investorroom.com/events-webcasts. Perrigo Company plc, a leading global healthcare company, delivers value to its customers and consumers by providing Quality Affordable Healthcare Products®. Founded in 1887 as a packager of home remedies, Perrigo has built a unique business model that is best described as the convergence of a fast-moving consumer goods company, a high-quality pharmaceutical manufacturing organization and a world-class supply chain network.

  • Company News For Nov 10, 2017
    Zackslast month

    Company News For Nov 10, 2017

    Companies in the News are: ROKU,M,SEDG,PRGO

  • Perrigo Co. Plc :PRGO-US: Earnings Analysis: Q3, 2017 By the Numbers : November 10, 2017
    Capital Cubelast month

    Perrigo Co. Plc :PRGO-US: Earnings Analysis: Q3, 2017 By the Numbers : November 10, 2017

    Categories: Yahoo FinanceGet free summary analysis Perrigo Co. Plc reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of Perrigo Co. Plc – United Therapeutics Corporation, Valeant Pharmaceuticals International Inc, Daiichi Sankyo Company, Limited and Catalent Inc (UTHR-US, VRX-US, DSKYF-US and CTLT-US) that have also reported for ... Read more (Read more...)

  • Perrigo Co. Plc breached its 50 day moving average in a Bullish Manner : PRGO-US : November 10, 2017
    Capital Cubelast month

    Perrigo Co. Plc breached its 50 day moving average in a Bullish Manner : PRGO-US : November 10, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Perrigo Co. Plc. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish ... Read more (Read more...)